| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Sildenafil |
| Brand | Revatio® |
| Indication | (a) For the treatment of adult patients with pulmonary arterial hypertension classified as WHO functional class II and III, to improve exercise capacity. (b) For the treatment of paediatric patients aged 1 year to 17 years old with pulmonary arterial hypertension. |
| Assessment Process | |
| Rapid review commissioned | 16/04/2014 |
| Rapid review completed | 23/05/2014 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation not Recommended |
